For colorectal cancer screening, the predictive value of distal findings in the ascertainment of proximal lesions is not fully established. The aims of this study were to assess distal findings as predictors of advanced proximal neoplasia and to compare the predictive value of endoscopy alone vs. combined endoscopic and histopathologic data.
INTRODUCTION
Most colorectal cancers (CRC) develop from adenomas, [1] [2] [3] which have a long, asymptomatic phase during which they are detectable and curable. Excision of colorectal adenomas reduces the incidence and the mortality of CRC. 2, [4] [5] [6] [7] [8] [9] [10] [11] Therefore, CRC fulfills the criteria for benefit from screening. 12 In 1996, the United States Preventive Services Task Force recommended screening of asymptomatic adults over 50 years of age with either flexible sigmoidoscopy (FS) or fecal occult blood tests (FOBT). 13 These recommendations now are endorsed by the American Cancer Society, 14 the World Health Organization, 15 and by virtually all medical and surgical professional societies concerned with digestive diseases. 16, 17 A positive FS or FOBT result is an indication for colonoscopy. The continuing high mortality rates for patients with CRC, together with two large studies that demonstrate that FS fails to identify a substantial proportion of proximal lesions, 18, 19 have led many specialists to regard reliance on FS or FOBT alone as screening tests would be as wrong as mammography of a single breast in screening for breast cancer. 12 A more detailed assessment of the costeffectiveness of alternative screening procedures 20 has led to somewhat surprising conclusions that may favor colonoscopy as a primary test. 21 However, cost is a major limitation to screening, and a more thorough assessment of the predictive value of findings derived from FS to ascertain proximal lesions is needed before accepting colonoscopy as a primary screening modality. Direct comparisons of distal colon examinations vs. colonoscopy are useful to determine the potential additional benefit of examination of the entire colon. Most studies of the association between distal and proximal neoplasia are compromised by selection bias, including specific subgroups. [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] Only studies wherein colonoscopy is offered as a primary screening procedure can appropriately address this issue. Currently, such data that are available derive from 3 studies that comprise relatively few cases [36] [37] [38] and two large studies carried out in the United States. 18, 19 These large studies from the United States assess the usefulness of applying endoscopic and histopathologic findings in the distal colon to predict the likelihood of finding advanced proximal neoplasms. However, the value of endoscopic distal findings alone has not been compared with the predictive power of combined distal endoscopic and histopathologic data. Additional assessments of the relative importance and predictive value of the findings in the distal colon are required to guide clinical decision making. The primary aim of this study was to determine the diagnostic utility of distal colonic polyps for detecting advanced proximal colonic neoplasms (APN) in an average-risk population undergoing primary screening colonoscopy in a Mediterranean country. A secondary objective was to compare the predictive value of distal endoscopic findings alone with combined endoscopic and histopathologic data.
PATIENTS AND METHODS

Study design
The study design was a retrospective analysis of asymptomatic, average-risk adults who were consecutively referred for screening colonoscopy to a university medical center endoscopy unit between 1988 and 1998. The study protocol was approved by a central human-rights committee, and written consent was required in all cases before colonoscopy.
Patients
Participants were included in the study if they presented to our clinic for a routine health evaluation and if they were considered to be at average risk for CRC after a medical interview. Our clinic is a private center that attracts patients from throughout Spain. The patients were referred to the endoscopy unit by specialists in internal medicine working in a health evaluation unit in our center. The policy for general health evaluation specifies colonoscopy for all patients older than 40 years. This policy was established in 1988, before the publication of American Gastroenterological Association guidelines for CRC screening. 16 Patients were excluded if they had undergone colonoscopy or sigmoidoscopy in the previous 5 years or reported hematochezia, change in bowel habit, or persistent abdominal or rectal pain. Other exclusion criteria were age less than 40 years or greater than 90 years; iron deficiency anemia; weight loss; history of colon polyps or cancer; a first-degree relative with CRC; a history of breast or uterine cancer, inflammatory bowel disease, abdominal radiation, colonoscopy, or barium enema within the previous 5 years, performed for any indication; and use of anticoagulant medication. Patients who had an incomplete colonoscopy (2.2%) also were excluded from the analysis.
Study procedures and definitions
Colonoscopies were performed by staff gastroenterologists (7) or gastroenterology fellows (in their third or fourth year of fellowship) under the supervision of a staff gastroenterologist. All polyps visualized were removed by standard electrosurgical snare polypectomy.
The following endoscopic findings were assessed: (1) location of the polyp(s) or cancer (endoscopist-estimated polyp location on withdrawal of the colonoscope by using landmarks and length of insertion tube within the patient), (2) number of polyps, and (3) polyp size (when seen intact or first removed). Size was confirmed by measuring the maximum diameter of the specimen when using an opened biopsy forceps as a visual guide.
Polyps were defined as distal if located in the descending colon, sigmoid colon, or rectum; polyps in any other segment were designated proximal. Standard methods were used for histopathologic processing and analysis of colorectal polyps. 39, 40 All specimens were reviewed by a pathologist with special expertise in GI pathology. When there was uncertainty, especially for advanced lesions, the case was reviewed at an intradepartment meeting and a diagnosis was made by consensus. Patients with multiple polyps were categorized according to the polyp with largest diameter, the most atypical histology (villous, tubulovillous, tubular), and the most severe grade of dysplasia. 41 An 'advanced neoplasm' was defined as any adenoma 1 cm or greater in size, and/or with a villous (or tubulovillous) morphology, and/or with high-grade dysplasia or invasive cancer. Patients with intramucosal carcinoma or carcinoma in situ were classified as having high-grade dysplasia. Invasive cancer was defined as the invasion of malignant cells beyond the muscularis mucosa.
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Statistical analysis
Logistic regression 42 was used to identify independent predictors of APN (any adenoma ≥1 cm in size, and/or with villous or tubulovillous morphology, and/or with highgrade dysplasia or invasive cancer). Univariate logistic regression analyses were performed to determine candi-date variables (i.e., those found to be significant at the level p < 0.25) for the subsequent multivariate logistic regression analysis, which was conducted to identify those variables with significant independent effects after adjusting for the effects of each of the other variables. Because the latter analysis was considered definitive, there was no need to correctp values to recognize that there was multiple testing of data arising from individual patients. Age, gender, and endoscopic and combined endoscopic and histopathologic data for distal polyps were entered as independent variables. Endoscopic data included two variables: number of polyps (0, 1, 2, ≥3) and maximum size (no polyp, ≤5 mm, 6 9 mm, ≥10 mm). Combined endoscopic and histopathologic data included the following: histopathologic classification (nonpolyp, hyperplastic, nonadvanced adenoma ≤5 mm, nonadvanced adenoma >5 and <10 mm, and advanced neoplasm) and number of adenomas (0, 1, 2, ≥3). Age and genderadjusted odds ratios (OR) for APN were calculated in two different logistic regression models that analyzed the following: (1) endoscopic distal findings and (2) combined distal endoscopic and histopathologic data. That the models adequately fit the data was checked with the Hosmer-Lemeshow goodness-of-fit test. The ability of the models to predict the existence of APN was assessed by estimation of the proportion of cases correctly predicted by each model, by calculating the area under the receiver operating characteristic (ROC) curve. 43 The diagnostic yield of different screening strategies was studied based upon distal findings by means of sensitivity, positive likelihood ratio, positive predictive value (PPV), and number of complete colonoscopies needed with each strategy. 44 A brief meta-analyses encompassing this and other relevant studies 18, 19 was conducted (results are stated in the discussion section). Meta-analytic summary statistics were calculated based on the methods in Takkouche et al. 45 
RESULTS
Screening colonoscopy was performed in 2210 consecutive average-risk patients (mean age 57.9; 74.6% men). Recruitment methods were routine health evaluation (1547 patients, 70.0%) and followup of a stable medical problem (663 patients, 30.0%). There were 178 patients (8.05%) who were older than 70 years, and 445 (20.14%) were from 40 to 49 years of age. Colonic polyps were detected in 825 (37.3%) and neoplastic lesions in 617 (28%) patients. Advanced neoplasms were found in 156 patients (7%). Invasive carcinoma was detected in 11 patients. All of these lesions were identified before there was apparent extracolonic spread of the disease. Among 56 patients (2.5%) with APN, 22 (39.3%) had no index distal polyp, 33 (58.9%) had at least one index distal adenoma, and 19 (33.9%) had at least one advanced distal neoplasm ( Table 1 ). None of the 56 patients with APN in this study had hyperplastic distal polyps alone. In 144 patients, all distal colonic polyps were completely destroyed during resection and histopathologic data could not be obtained. Only one of these patients (1.8%) had an APN.
Diagnostic yield of different screening strategies based upon distal findings
The use of more flexible criteria for the definition of a positive sigmoidoscopy improved diagnostic sensitivity (for detection of patients with APN) (Table 2) . However, the use of more flexible criteria also was associated with a larger proportion of patients undergoing sigmoidoscopy who are referred for subsequent colonoscopy.
The proportion of patients with various distal findings who had APN ( Table 2 ).
The increase in sensitivity of screening strategies in which colonoscopy would be indicated for patients with small polyps or small nonadvanced distal adenomas (>5 and <10 mm) was related not only to the larger proportion of patients who would undergo colonoscopy (from 4.7%/5.4% to 12.2%/10.8%; Table 2 ), but also to a higher PPV in these groups (PPV, 6.7%; 
1])
. The increase in sensitivity in screening strategies that indicated colonoscopy for these groups could be accounted for almost exclusively by the larger fraction of patients in these groups undergoing colonoscopy (respectively, 20.4% and 30.2%; Table 2 ).
Predictors of advanced proximal neoplasms
In univariate analyses, age, gender, and endoscopic and histopathologic characteristics of distal polyps were considered potential predictors of APN (p < 0.25).
In multivariate analyses, age and gender were independent predictors of APN (p<0.05). For each year over 40 years of age, the risk increased by 5% (Table 4 ). The size of distal polyps was found to be the best endoscopic predictor of APN after adjustment for age and gender (Table 4 , model A). Combining histopathologic and endoscopic findings (Table 4 , model B) led to high ORs for advanced distal adenomas but also for nonadvanced small adenomas (6-9 mm in size). Distal lesions 5 mm or less in size (polyps in model A and adenomas in model B) were not found to be independently associated with a significantly greater risk of APN, unless they were multiple (≥3).
The addition of any distal finding to age and gender increased the proportion of patients correctly predicted by the models (Table 5 ). It is noted that the areas under the ROCs for «any distal polyp greater than 5 mm in size" in the endoscopic model, for «any distal adenoma" in the combined model, and for maximum predictive potential in each of the endoscopic and combined models were significantly greater than the area under the ROC for the baseline (age and gender only) model. However, maximum area under the ROC was always lower than 80%, regardless of the number of variables included in the multivariate model. Negligible differences in the predictive value (area under ROC) were found when only endoscopic data were considered vs. when comparable histopathologic data were added to build the models.
DISCUSSION
This is the third study of the use of colonoscopy as a primary screening procedure in a large number of verage-risk adults 18, 19 and the first study conducted outside the United States. Because the study included consecutive colonoscopies in average-risk patients, who freely came to our clinic for a routine health evaluation, the results apply to decision making regarding the use of colonoscopy as a primary screening modality in the general population.
Age and gender were independent risk factors for APN. For each year of age after 40 years, the risk increased by 5% (after adjustment for gender and distal findings). This estimate is similar to that found in other studies. 19 Our clinic is a private institution, and many of our patients have private health insurance. This may be the reason for so many men in the study population (74.6%). Men are known to have an increased age-related risk for colon neoplasia. Over a lifetime, women have a risk of CRC similar to that of men (because they live 5-7 years longer). Although men are known to be at increased risk of colorectal neoplasia, specific differences regarding APN have not been fully established. 19, 46, 47 Information on the prevalence of isolated APN was not available until recently. 18, 19 In the present study, patients with no distal adenomas had a risk of APN of 1.3%, a proportion similar to that reported recently for the United States. Consistent with other studies, 18, 19, [48] [49] [50] [51] [52] the data from the present study show that 40% of APN (22 of 56) would not have been detected if only the distal colon had been examined, even if FS were followed by colonoscopy when any index distal polyp (hyperplastic or adenoma) was found (Table 1) .
Three studies have evaluated the predictive ability of lesions in the distal colon for the risk of APN (Table 6 ). Summarizing the sensitivity of these studies, 61.1% of patients with APN (95% CI[54.9, 68.0]) had at least one index distal polyp, and 50.1%: 95% CI [43.8, 57.4] had at least one index distal adenoma.
To estimate the probability of APN, considering distal polyp characteristics, age, and gender together increases the predictive ability, but the area under the ROC was lower than 80% for all models that stratify patients according to different distal findings. The area under the curve can be directly interpreted as the predicted probability of a test to classify correctly a pair of patients, one with and one without the disease (APN in the present study). This highlights the limitations of findings at FS in predicting APN. The predictive ability of models that included endoscopic data alone was similar to that observed in models that also included histopathologic data. These results support the screening strategy proposed by Stern et al., 53 which provides comprehensive CRC screening in a single visit by converting from sigmoidoscopy to colonoscopy, depending on distal endoscopic findings. This strategy may reduce the costs of traditional endoscopic screening. 54 Imperiale et al. 19 found a significant association between hyperplastic distal polyps and APN. Our results, however, confirm those of other studies 18, 32, [55] [56] [57] [58] [59] that show that hyperplastic polyps are not predictors of APN. Results differ when the predictive value of different characteristics of distal adenomas were studied in multivariate anal yses. [24] [25] [26] [27] 29, [33] [34] [35] 46, 58, [60] [61] [62] [63] [64] The results of the current study are consistent with those of previous studies that demonstrate the importance of advanced distal neoplasms as a marker of APN. In fact, pooling of our results with those of previous studies 18, 19 The present study has some limitations. First, although the procedures performed remained essentially unchanged over the 10 years of the study, some heterogeneity across time can be expected. Second, there is a possibility of self-selection bias, because the study included patients who exhibited healthseeking behavior. However, there is not sufficient evidence that such behavior modifies the effect of the variables studied. Third, distal colonoscopic findings were used as a surrogate for findings at sigmoidoscopy. The descending colon may not be reached with a sigmoidoscope, or the examination may be limited by suboptimal bowel preparation. Therefore, the present study provides an estimate of the maximum predictive ability of sigmoidoscopy. Fourth, the data alone may not be sufficient for deciding which technique is best for primary CRC screening.
Other information, such as the expense and complications of colonoscopy and the natural history of advanced neoplasms, also are relevant. The use of colonoscopy to screen asymptomatic individuals for CRC is feasible and may be the best alternative for identification of patients who may benefit from early detection and removal of potentially malignant lesions. The data from the present study highlight some of the limitations of FS as a primary CRC screening test. The study found that many patients with APN would not be identified by FS and that the risk of APN is associated with increasing age and male gender. If a primary goal of screening is the detection and removal of advanced adenomas, colonoscopy offers more effective screening than sigmoidoscopy. 
